EyePACS

EyePACS is a U.S. teleophthalmology and digital health company focused on diabetic retinopathy screening and retinal assessment in primary care and community health settings. The company provides a cloud-based platform, clinical workflow, image management, and specialist interpretation services that allow clinics to capture retinal images and receive evidence-based grading and follow-up recommendations. EyePACS has been widely deployed across community clinics and health systems and has supported large-scale blindness-prevention programs. Its business is service- and platform-oriented rather than drug-development focused, with commercial offerings centered on screening operations, camera integration, and telemedicine infrastructure. In November 2025, EyePACS was acquired by Optain Health, with the platform reported to continue operating while being integrated over time.